CANCIDAS 70 MG — DIN 02244266
CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG · MERCK CANADA INC · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is CANCIDAS?
CANCIDAS 70 MG contains CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG. It is listed in the Health Canada Drug Product Database under DIN 02244266, held by MERCK CANADA INC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 05-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Caspofungin cost around the world?
Caspofungin is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Italy publishes a ex-factory (classe H); Romania publishes a max producer price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 18 | 18 | ZAR███.██ |
| Romania | max producer price | 13 | 15 | RON███.██ |
| Italy | ex-factory (classe H) | 6 | 14 | EUR███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| Saudi Arabia | public | 10 | 12 | SAR███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
74 pack listings across 62 brand entries and 6 price bases, refreshed 03 Sep 2026. Ranges span every Caspofungin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Caspofungin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Caspofungin, across 12 DINs, of which 5 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| FRESENIUS KABI CANADA LTD | 2 | 2 | CASPOFUNGIN FOR INJECTION | Sourceable in Canada |
| JUNO PHARMACEUTICALS CORP. | 2 | 2 | CASPOFUNGIN FOR INJECTION | Sourceable in Canada |
| MERCK CANADA INC | 2 | 1 | CANCIDAS | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 2 | 0 | CASPOFUNGIN ACETATE FOR INJECTION | No marketed DIN |
| STERIMAX INC | 2 | 0 | CASPOFUNGIN ACETATE FOR INJECTION | No marketed DIN |
| TEVA CANADA LIMITED | 2 | 0 | CASPOFUNGIN POWDER FOR INJECTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 70 MG |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRAVENOUS |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Caspofungin |
|---|---|
| ATC code | J02AX04 |
| AHFS class | 08:14.16 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02244266 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2244266 |
| Brand name | CANCIDAS |
| Generic / active ingredient | CASPOFUNGIN (CASPOFUNGIN ACETATE) : 70 MG |
| Market authorization holder | MERCK CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | J02AX04 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J02AX |
| Current status | MARKETED |
| Status date | 05-Jul-2006 |
| Original market date | 2001-10-23 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Caspofungin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Discontinued — reported by FRESENIUS KABI CANADA LTD, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
5 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CASPOFUNGIN FOR INJECTION | 50 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02460947 |
| CASPOFUNGIN FOR INJECTION | 70 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02486997 |
| CASPOFUNGIN FOR INJECTION | 50 MG | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02486989 |
| CASPOFUNGIN FOR INJECTION | 70 MG | POWDER FOR SOLUTION | JUNO PHARMACEUTICALS CORP. | MARKETED | 02460955 |
| CANCIDAS | 50 MG | POWDER FOR SOLUTION | MERCK CANADA INC | CANCELLED POST MARKET | 02244265 |
| CASPOFUNGIN ACETATE FOR INJECTION | 70 MG | POWDER FOR SOLUTION | STERIMAX INC | APPROVED | 02456125 |
| CASPOFUNGIN ACETATE FOR INJECTION | 50 MG | POWDER FOR SOLUTION | STERIMAX INC | APPROVED | 02456133 |
| CASPOFUNGIN ACETATE FOR INJECTION | 70 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | 02389207 |
| CASPOFUNGIN ACETATE FOR INJECTION | 50 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | 02389193 |
| CASPOFUNGIN POWDER FOR INJECTION | 70 MG | POWDER FOR SOLUTION | TEVA CANADA LIMITED | CANCELLED PRE MARKET | 02448823 |
2 · Same class — other molecules in ATC J02AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Micafungin | MICAFUNGIN FOR INJECTION · MICAFUNGIN SODIUM FOR INJECTION · MYCAMINE | 10 | 6 | Yes |
| Caspofungin | CANCIDAS · CASPOFUNGIN ACETATE FOR INJECTION · CASPOFUNGIN FOR INJECTION · CASPOFUNGIN POWDER FOR INJECTION | 12 | 5 | Yes |
| Anidulafungin | ERAXIS · GD-ANIDULAFUNGIN | 3 | 1 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J02AC | Fluconazole · Isavuconazole · Itraconazole · Posaconazole · Voriconazole | 115 | 54 |
| J02AA | Amphotericin B | 7 | 2 |
| J02AB | Ketoconazole | 5 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CANCIDAS called?
Also recorded in Canada as: CASPOFUNGIN ACETATE (US), CASPOFUNGIN ACETATE (UK), CASPOFUNGIN ACETATE (JP), CASPOGIN (IN), CASFUN (IN), CASPONEX (IN).
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.